Pan‐cancer clinical and molecular analysis of racial disparities

Racial disparities in cancer outcomes are increasingly recognized, but comprehensive analyses, including molecular studies, are limited. The objective of the current study was to perform a pan‐cancer clinical and epigenetic molecular analysis of outcomes in African American (AA) and European American (EA) patients.

[1]  A. Jemal,et al.  Cancer statistics for African Americans, 2019 , 2019, CA: a cancer journal for clinicians.

[2]  R. Moonesinghe,et al.  Racial/Ethnic Disparities in Mortality: Contributions and Variations by Rurality in the United States, 2012–2015 , 2019, International journal of environmental research and public health.

[3]  E. Giovannetti,et al.  Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma , 2018, Annals of surgery.

[4]  T. Rebbeck,et al.  Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. , 2018, Cancer cell.

[5]  Y. Nie,et al.  Dysregulated microRNA expression profiles in gastric cancer cells with high peritoneal metastatic potential , 2018, Experimental and therapeutic medicine.

[6]  Liang Zhou,et al.  Oncogene miR‐154‐5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma , 2018, Life sciences.

[7]  C. Patten,et al.  Stress and Achievement of Cardiovascular Health Metrics: The American Heart Association Life's Simple 7 in Blacks of the Jackson Heart Study , 2018, Journal of the American Heart Association.

[8]  Andrew P Feinberg,et al.  The Key Role of Epigenetics in Human Disease Prevention and Mitigation. , 2018, The New England journal of medicine.

[9]  Clement Adebamowo,et al.  Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context , 2018, Cell reports.

[10]  J. Jassem,et al.  MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma. , 2018, Lung cancer.

[11]  Youwei Zhu,et al.  MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes. , 2018, Cancer letters.

[12]  Xiuxia Zheng,et al.  MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1. , 2017, Cancer biomarkers : section A of Disease markers.

[13]  S. Gabriel,et al.  Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations. , 2017, Cancer discovery.

[14]  Aamir Ahmad,et al.  Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings , 2017, Carcinogenesis.

[15]  L. Newman,et al.  Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer , 2017, JAMA oncology.

[16]  James E Carter,et al.  Epigenetic basis of cancer health disparities: Looking beyond genetic differences. , 2017, Biochimica et biophysica acta. Reviews on cancer.

[17]  Aiko Sueta,et al.  Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence , 2017, Oncotarget.

[18]  Krista A. Zanetti,et al.  Novel colon cancer susceptibility variants identified from a genome‐wide association study in African Americans , 2017, International journal of cancer.

[19]  He-da Zhang,et al.  The role of miR-130a in cancer , 2017, Breast Cancer.

[20]  A. Izzotti,et al.  Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators. , 2017, American journal of cancer research.

[21]  Y. Tao,et al.  Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians , 2017, Breast Cancer Research and Treatment.

[22]  Allison P. Heath,et al.  Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.

[23]  Wei Ma,et al.  Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy , 2016, Scientific Reports.

[24]  Levi Waldron,et al.  Racial/Ethnic Disparities in Genomic Sequencing. , 2016, JAMA oncology.

[25]  David R. Williams,et al.  Understanding and effectively addressing breast cancer in African American women: Unpacking the social context , 2016, Cancer.

[26]  K. Straif,et al.  Carcinogenicity of drinking coffee, mate, and very hot beverages. , 2016, The Lancet. Oncology.

[27]  Ting Deng,et al.  Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer , 2016, Oncotarget.

[28]  L. Rolnitzky,et al.  Preoperative experience for public hospital patients with gynecologic cancer: Do structural barriers widen the gap? , 2016, Cancer.

[29]  Hiroshi Egawa,et al.  The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN , 2016, Scientific Reports.

[30]  Zhihua Liu,et al.  Overexpression of S100A14 in human serous ovarian carcinoma. , 2016, Oncology letters.

[31]  DongXu He,et al.  Transient receptor potential channel C5 in cancer chemoresistance , 2015, Acta Pharmacologica Sinica.

[32]  Paul L. Roebuck,et al.  TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. , 2015, Cancer research.

[33]  S. Olson,et al.  The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[34]  Wei-wei Yu,et al.  miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3 , 2015, Oncology reports.

[35]  A. Singh,et al.  Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation , 2015, Oncotarget.

[36]  L. Newman.  Disparities in Breast Cancer and African Ancestry: A Global Perspective , 2015, The breast journal.

[37]  Daozhen Chen,et al.  Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance , 2014, Proceedings of the National Academy of Sciences.

[38]  C. Shriver,et al.  Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer , 2014, BMC Cancer.

[39]  L. Harris,et al.  Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy , 2013, PloS one.

[40]  Andrew E. Teschendorff,et al.  Age-associated epigenetic drift: implications, and a case of epigenetic thrift? , 2013, Human molecular genetics.

[41]  S. Vacher,et al.  microRNA expression profile in a large series of bladder tumors: Identification of a 3‐miRNA signature associated with aggressiveness of muscle‐invasive bladder cancer , 2013, International journal of cancer.

[42]  C. Croce,et al.  miR-15a and miR-16-1 in cancer: discovery, function and future perspectives , 2010, Cell Death and Differentiation.

[43]  R. Stephens,et al.  Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients , 2009, PloS one.

[44]  G. Maxwell,et al.  Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. , 2009, Cancer control : journal of the Moffitt Cancer Center.

[45]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[47]  Stan Pounds,et al.  Estimating the Occurrence of False Positives and False Negatives in Microarray Studies by Approximating and Partitioning the Empirical Distribution of P-values , 2003, Bioinform..

[48]  Colin B Begg,et al.  Survival of blacks and whites after a cancer diagnosis. , 2002, JAMA.

[49]  V. Shavers,et al.  Racial and ethnic disparities in the receipt of cancer treatment. , 2002, Journal of the National Cancer Institute.

[50]  B. Hankey,et al.  A collaborative study of differences in the survival rates of black patients and white patients with cancer , 1992, Cancer.

[51]  C. Boring,et al.  Cancer statistics for african americans , 1992, CA: a cancer journal for clinicians.